FDA Adverse Event Malfunction Summary report: N

CAPIOX FX25 OXYGENATOR

MDR report key: 11670147 · Received April 15, 2021

Report

Report Number
9681834-2021-00063
Event Type
Malfunction
Date Received
April 15, 2021
Date of Event
March 30, 2021
Report Date
April 15, 2021
Manufacturer
TERUMO CORPORATION, ASHITAKA
Product Code
DTZ
UDI-DI
04987350701046
PMA / PMN Number
K071494
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUBMITTED AS FOLLOW UP NO. 1 TO UPDATE SECTION H3, AND TO PROVIDE THE COMPLETED INVESTIGATION RESULTS. THE ACTUAL SAMPLE WAS RECEIVED FOR EVALUATION. VISUAL INSPECTION WITH THE UNAIDED EYE CONFIRMED THAT THE PURGE LINE TUBE HAD BEEN CRACKED AND ALMOST SEPARATED FROM THE JOINT WITH THE OXYGENATOR PORT. THE CRACK SURFACE OF THE PURGE LINE TUBE WAS INSPECTED UNDER A MAGNIFICATION AND ELECTRON MICROSCOPE. IT WAS FOUND SMOOTH, WHICH INFERRED THAT THE CRACK MAY HAVE CAUSED DUE TO HAVING BEEN EXPOSED TO A MOMENTANEOUS SHOCK LOAD. THERE WAS NOT ANY FOREIGN SUBSTANCE OR AIR EMBEDDED IN THE MATERIAL, WHICH COULD BE A TRIGGER OF THE BREAKAGE. THE PURGE LINE TUBE OF THE ACTUAL SAMPLE WAS CUT, AND THE CROSS-SECTION WAS INSPECTED UNDER MAGNIFICATION. THE WALL THICKNESS WAS CONFIRMED EVEN. THE OUTSIDE AND INSIDE DIAMETERS OF THE TUBE WERE MEASURED. COMPARED TO THE CURRENT PRODUCT SAMPLE, NO DIFFERENCE IN THE MEASURED VALUES WAS CONFIRMED. REPRODUCTIVE TEST/LOW-TEMPERATURE FRAGILITY TESTING WAS PERFORMED AND ASSUMING THAT THE FRACTURE OCCURRED DURING TRANSPORTATION OR STORAGE, MULTIPLE TEST SAMPLES PACKED IN THE UNIT BOXES WERE COOLED, AND THEN DROPPED FROM 1.5 METER HIGH. AS A RESULT, SOME OF THE TUBES WERE FRACTURED AT THE JOINT WITH THE PRODUCT. THE FRACTURE SURFACE OF THE FRACTURED TUBE WAS EVALUATED AND CONFIRMED TO BE SIMILAR TO THAT OF THE FRACTURED PURGE LINE TUBE OF THE ACTUAL SAMPLE. THE TEST CONDITION WAS SET DISCRETIONARILY. IFU STATES: IF THE PRODUCT IS DROPPED DURING SET-UP, DO NOT USE IT. REPLACE WITH ANOTHER DEVICE. BASED ON THE PROVIDED INFORMATION AND INVESTIGATION RESULTS, THERE IS NO DEFINITIVE EVIDENCE THAT THIS EVENT WAS RELATED TO A DEVICE DEFECT OR MALFUNCTION. IT IS LIKELY THAT THE PRODUCT WAS CHILLED UNDER LOW TEMPERATURE ENVIRONMENT DURING TRANSPORTATION OR STORAGE IN THE COLD SEASON, AND THE PRODUCT IN THAT CHILLED STATE WAS EXPOSED TO STRONG IMPACT LOAD DURING BEING HANDLED, WHICH RESULTED IN THE CRACK OF THE PURGE LINE TUBE. HOWEVER, THE EXACT CAUSE OF THE REPORTED EVENT CANNOT BE DEFINITIVELY DETERMINED BASED ON THE AVAILABLE INFORMATION.

Additional Manufacturer Narrative · 1

ADDRESS: (B)(6) HOSPITAL. PMA/510(K): K130280. THE ACTUAL DEVICE HAS BEEN RETURNED FOR EVALUATION. THE INVESTIGATION IS CURRENTLY ONGOING. A FOLLOW UP REPORT WILL BE SUBMITTED ONCE THE INVESTIGATION IS COMPLETE. A REVIEW OF THE DEVICE HISTORY RECORD AND PRODUCT-RELEASE JUDGEMENT RECORD OF THE INVOLVED PRODUCT CODE/LOT# COMBINATION WAS CONDUCTED WITH NO FINDINGS. TERUMO MEDICAL PRODUCTS (TMP) (IMPORTER) REGISTRATION NO. (B)(4) IS SUBMITTING THIS REPORT ON BEHALF OF ASHITAKA FACTORY OF TERUMO CORPORATION (MANUFACTURER) REGISTRATION NO. (B)(4).

Description of Event or Problem · 1

THE USER FACILITY REPORTED THE CAPIOX DEVICE WAS USED PRE-TREATMENT. LEAKAGE: THE OPERATOR FOUND LIQUID LEAK FROM THE PURGE PORT DURING PRIMING. THE PROCEDURE OUTCOME WAS NOT REPORTED. THE PATIENT WAS NOT HARMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
569397 CAPIOX FX25 OXYGENATOR OXYGENATOR, CARDIOPULMONARY BYPASS DTZ TERUMO CORPORATION, ASHITAKA NA 200914C 04987350701046

Patients

Seq Age Sex Outcome Treatment
1 49 YR